References
- Durczynski A, Hogendorf P, Szymanski D, et al. Insulinoma—rare, but important clinical problem. Analysis of a series of 530 patients who underwent surgical treatment for the pancreatic tumor. Polski Przeglad Chirurgiczny. 2014;86:505–510.
- Shin JJ, Gorden P, Libutti SK. Insulinoma: pathophysiology, localization and management. Future Oncol. 2010;6:229–237.
- Antonakis PT, Ashrafian H, Martinez-Isla A. Pancreatic insulinomas: laparoscopic management. World J Gastrointest Endosc. 2015;7:1197–1207.
- Whipple AO, Frantz VK. Adenoma of islet cells with hyperinsulinism: a review. Ann Surg. 1935;101:1299–1335.
- Li X, Zhang F, Chen H, et al. Diagnosis of insulinoma using the ratios of serum concentrations of insulin and C-peptide to glucose during a 5-hour oral glucose tolerance test. Endocr J. 2017;64:49–57.
- Ahn CH, Kim LK, Lee JE, et al. Clinical implications of various criteria for the biochemical diagnosis of insulinoma. Endocrinol Metab (Seoul). 2014;29:498–504.
- Aggeli C, Nixon AM, Karoumpalis I, et al. Laparoscopic surgery for pancreatic insulinomas: an update. Hormones (Athens). 2016;15:157–169.
- Jensen RT, Cadiot G, Brandi ML, et al. ENETS Consensus Guidelines for the management of patients with digestive neuroendocrine neoplasms: functional pancreatic endocrine tumor syndromes. Neuroendocrinology. 2012;95:98–119.
- Qin SY, Lu XP, Jiang HX. EUS-guided ethanol ablation of insulinomas: case series and literature review. Medicine (Baltimore). 2014;93:e85.
- Moore TJ, Peterson LM, Harrington DP, et al. Successful arterial embolization of an insulinoma. JAMA. 1982;248:1353–1355.
- Mathur A, Gorden P, Libutti SK. Insulinoma. Surg Clin N Am. 2009;89:1105–1121.
- Jurgensen C, Schuppan D, Neser F, et al. EUS-guided alcohol ablation of an insulinoma. Gastrointest Endosc. 2006;63:1059–1062.
- Gagner M, Pomp A, Herrera MF. Early experience with laparoscopic resections of islet cell tumors. Surgery. 1996;120:1051–1054.
- Armellini E, Crino SF, Ballare M, et al. Endoscopic ultrasound-guided ethanol ablation of pancreatic neuroendocrine tumours: a case study and literature review. World J Gastrointest Endosc. 2016;8:192–197.
- Wei J, Liu X, Wu J, et al. Diagnosis and surgical management of insulinomas in 33 consecutive patients at a single institution. Langenbecks Arch Surg. 2016;401:1019–1025.
- Levy MJ, Thompson GB, Topazian MD, et al. US-guided ethanol ablation of insulinomas: a new treatment option. Gastrointest Endosc. 2012;75:200–206.
- Paik WH, Seo DW, Dhir V, et al. Safety and efficacy of EUS-guided ethanol ablation for treating small solid pancreatic neoplasm. Medicine (Baltimore). 2016;95:e2538.
- Yang D, Inabnet WB, 3rd, Sarpel U, et al. EUS-guided ethanol ablation of symptomatic pancreatic insulinomas. Gastrointest Endosc. 2015;82:1127.
- Lakhtakia S, Seo DW. EUS-guided tumor ablation. Dig Endosc. 2017;29:486–494.
- Metz DC, Jensen RT. Gastrointestinal neuroendocrine tumors: pancreatic endocrine tumors. Gastroenterology. 2008;135:1469–1492.
- Grant CS. Insulinoma. Best Pract Res Clin Gastroenterol. 2005;19:783–798.
- Tucker ON, Crotty PL, Conlon KC. The management of insulinoma. Br J Surg. 2006;93:264–275.
- Sotoudehmanesh R, Hedayat A, Shirazian N, et al. Endoscopic ultrasonography (EUS) in the localization of insulinoma. Endocrine. 2007;31:238–241.
- Noone TC, Hosey J, Firat Z, et al. Imaging and localization of islet-cell tumours of the pancreas on CT and MRI. Best Pract Res Clin Endocrinol Metabol. 2005;19:195–211.
- Goh BK, Ooi LL, Cheow PC, et al. Accurate preoperative localization of insulinomas avoids the need for blind resection and reoperation: analysis of a single institution experience with 17 surgically treated tumors over 19 years. J Gastrointest Surg. 2009;13:1071–1077.
- Duffy DM. Sclerosants: a comparative review. Dermatol Surg. 2010;36 Suppl 2:1010–1025.
- Dell'Atti L. Comparison between the use of 99% ethanol and 3% polidocanol in percutaneous echoguided sclerotherapy treatment of simple renal cysts. Urol Ann. 2015;7:310–314.
- Xue J, Geng X. Curative effect of lauromacrogol and absolute ethyl alcohol injection guided by ultrasound on simplex hepatic cyst. Pak J Pharm Sci. 2015;28:697–700.
- King JT, O'Byrne M, Vasquez M, et al. Treatment of truncal incompetence and varicose veins with a single administration of a new polidocanol endovenous microfoam preparation improves symptoms and appearance. Eur J Vasc Endovasc Surg. 2015;50:784–793.
- Igawa A, Oka S, Tanaka S, et al. Major predictors and management of small-bowel angioectasia. BMC Gastroenterol. 2015;15:108.
- Igawa A, Oka S, Tanaka S, et al. Polidocanol injection therapy for small-bowel hemangioma by using double-balloon endoscopy. Gastrointest Endosc. 2016;84:163–167.
- Itou C, Koizumi J, Hashimoto T, et al. Balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices: polidocanol foam versus liquid ethanolamine oleate. AJR Am J Roentgenol. 2015;205:659–666.
- Kolvenbach H, Hirner A. Infected pancreatic necrosis possibly due to combined percutaneous aspiration, cystogastric pseudocyst drainage and injection of a sclerosant. Endoscopy. 1991;23:102–105.
- Linghu E, Du C, Chai N, et al. A prospective study on the safety and effectiveness of using lauromacrogol for ablation of pancreatic cystic neoplasms with the aid of EUS. Gastrointest Endosc. 2017;86:872–880.
- Bertanha M, Sobreira ML, Pinheiro Lucio Filho CE, et al. Polidocanol versus hypertonic glucose for sclerotherapy treatment of reticular veins of the lower limbs: study protocol for a randomized controlled trial. Trials. 2014;15:497.
- Kobayashi S, Crooks S, Eckmann DM. Dose- and time-dependent liquid sclerosant effects on endothelial cell death. Dermatol Surg. 2006;32:1444–1452.